Roche moves obesity drug to pivotal trials after mid-stage success
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q4 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
Long-Term Keto Diet Risks Raise Questions for Metabolic Health
A long-term study published in Science Advances has found that while a ketogenic diet limited weight gain in…
Big Food has devoured British farmers
Britain’s food system is a remarkable exercise in trusting strangers. We hope that the people who produce, transport…
Which breads are best — and the ‘healthy’ kind you should avoid
Bread is, well, on a roll. Though the average price of bread rose about 2.2% in the last…
Nearly half of adults now live with heart disease as obesity and diabetes surge
From rising obesity and diabetes to stubborn health inequities, the AHA’s latest statistics reveal why cardiovascular disease remains…
High BMI linked to vascular dementia risk
High body mass index (BMI) could cause a higher risk of vascular-related dementia (a combination of vascular +…
6 New Weight Loss Drugs That Could Dethrone Ozempic
The arrival of semaglutide and similar GLP-1 drugs in recent years has ushered in a new era of…
Sperm RNA aging shift that may explain paternal age effects
A newly revealed “aging cliff” in sperm RNA marks a conserved molecular transition from youth to later life,…
How “old RNA” reshapes sperm metabolism
Increasing paternal age has been linked to elevated health risks for the next generation, including higher risks of…
Lung cancer deaths leveling off for EU women, except in Spain
After increasing for more than 25 years, lung cancer death rates are finally levelling off among women in…